The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of NOTCH pathway-activated adenoid cystic carcinoma with and without co-occurrent TP53 mutation.
 
Syeda Malaika Haider
No Relationships to Disclose
 
Joseph Edward Haigh
Travel, Accommodations, Expenses - BeiGene
 
Karan Patel
No Relationships to Disclose
 
Samuel Rack
No Relationships to Disclose
 
Laura Spurgeon
No Relationships to Disclose
 
Guy Betts
Speakers' Bureau - Seagen (I)
(OPTIONAL) Uncompensated Relationships - MSD
 
Kevin Joseph Harrington
Honoraria - Arch Oncology (Inst); AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Codiak Biosciences (Inst); Inzen Therapeutics (Inst); Johnson and Johnson (Inst); Merck Serono (Inst); MSD (Inst); Nanobiotix (Inst); Oncolys BioPharma (Inst); Pfizer (Inst); Replimune (Inst); Scenic Biotech
Consulting or Advisory Role - Arch Oncology (Inst); AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Inzen Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Nanobiotix (Inst); Oncolys BioPharma (Inst); Replimune (Inst)
Speakers' Bureau - BMS (Inst); Merck Serono (Inst); MSD (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Replimune (Inst)
 
Robert Metcalf
Honoraria - Bristol-Myers Squibb; MSD; Sanofi
Consulting or Advisory Role - Achilles Therapeutics; Aptus Clinical; Ayala Pharmaceuticals; Bayer; OxSonics Therapeutics; PCI Biotech